Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1-4
|
pubmed:dateCreated |
1978-3-10
|
pubmed:language |
ger
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0003-9128
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
29
|
pubmed:volume |
224
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
359-60
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:579859-Antineoplastic Agents,
pubmed-meshheading:579859-Drug Evaluation, Preclinical,
pubmed-meshheading:579859-Female,
pubmed-meshheading:579859-Humans,
pubmed-meshheading:579859-Ovarian Neoplasms,
pubmed-meshheading:579859-Uridine,
pubmed-meshheading:579859-Uterine Cervical Neoplasms
|
pubmed:year |
1977
|
pubmed:articleTitle |
[The significance of Volm's oncobiogram for the therapy of advanced and recurring cervical cancer (proceedings)].
|
pubmed:publicationType |
Journal Article,
In Vitro
|